$KUAISHOU-W(01024.HK)$HENGRUI PHARMA(01276.HK)
Kuaishou's performance is quite poor, but the management of this company has little credibility to begin with. For me, this after-hours meeting doesn't add any new negative points.
I currently hold about a 2% position and have no intention of adding to it at the moment.
My Hengrui position is slightly larger than Kuaishou's, but I haven't had time to look into it closely yet.
However, looking at the stock price, even with such a strong run in the pharmaceutical sector, it still managed to drop. This suggests there are likely some significant underlying issues 🙃
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
